HomeTagsHealthcare

Healthcare

Stories from Healthcare come first, newest first, then stories from connected topics (healthcare AI, AI Science & Health, Hub: Tech for Good, Medicine, AI, AI for science), each labelled with where it comes from. This view is not indexed by search engines.

NIH-Backed Endometriosis Genomics Study Finds 58 Regions

An NIH-backed endometriosis genomics study of over 1 million people finds 58 regions in Nature Genetics. It is an association study, not a test or treatment.

Just in

Latest

IARC Launches INTERVENER Tool for Cancer Screening Barriers

IARC launched INTERVENER, a web tool matching cancer-screening barriers to evidence-based interventions. It is a planning tool, in English for now.

Bispecific Nanobody Neutralises Three Coronaviruses in Mice

A Georgia State-led bispecific nanobody neutralised all tested SARS-CoV, SARS-CoV-2 and MERS-CoV strains and protected mice. No human trials yet.

Boltz Raises $110 Million Series A for Molecular Design Tools

Boltz has raised a $110 million Series A led by Bessemer. The MIT-origin firm claims partnerships with six of the world's 20 largest pharma companies.

Sanger and CRG Map Hidden Drug Sites on Two Protein Families

Researchers at Sanger and CRG have published protein maps of GPCRs and transcription factors. The results are from lab and cell tests; no drug exists yet.

UNC13A Fix Restores Neuron Signalling in Lab MND Models

A Nature study says correcting one UNC13A splicing error restored signalling between human neurons in the lab. It is lab-only, with no patient data.

Alzheimer’s Amyloid Study Maps Two Toxic Routes in Mice

A Sheffield-led Alzheimer’s amyloid study mapped two toxic routes in mice and donated tissue. A protein reduced them in mice, not in patients.

Autoimmune AI Triage Trial Reports Shorter Diagnosis Times

Autoimmune AI triage at Vanderbilt was linked to 43 versus 138 days to diagnosis, Johns Hopkins says. The single-system trial tested referral alerts.

Blood Tests Plus CT or AI Improve Lung Cancer Identification

Catharina/TU/e: blood markers plus CT or AI identified ~73–78% of lung-cancer cases in 346 patients; AI comparable to radiologists. Research poster stage.

NYU Links ESCO2 Loss to PARP Inhibitor Sensitivity

PARP inhibitors: NYU maps ESCO2 loss as a sensitivity marker in cancer cell models via G4 stress — biomarkers, not a new therapy; more research needed.

RPI’s Quest2Dx AI Screens for Parkinson’s Using Health Questionnaires

RPI's Quest2Dx, a Parkinson's screening AI, flagged likely cases from health questionnaires in research data. It is a screening aid, not a diagnosis.

Latest on TSN

Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.